SB DRUG DISCOVERY LIMITEDActive
Key figures
Like most small UK companies, SB DRUG DISCOVERY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2021/22Balance sheet structure
Filed accounts2019/20–2021/22
| 2019/20 | 2020/21 | 2021/22 | |
|---|---|---|---|
| Cash at bank and in hand | 962,741 | 1,073,394 | 1,108,209 |
| Total assets | 1,935,563 | 2,388,564 | 2,943,963 |
| Total liabilities | — | — | 1,611,215 |
| Net assets / total equity | 1,309,856 | 1,802,147 | 2,143,309 |
| Average number of employees | 31 | 36 | 45 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SB DRUG DISCOVERY LIMITED
Company
SB DRUG DISCOVERY LIMITED is a private limited company registered with Companies House under company number SC237873. It was incorporated on 8 Oct 2002. Its status is active. The registered office is in Glasgow (G20). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2021/22 (period ending 31 Mar 2022); the company files small company accounts. Net assets were £2,143,309, up 18.9% on the previous year. Cash at bank and in hand was £1,108,209. Total assets were £2,943,963 and total liabilities £1,611,215. The company had an average of 45 employees. Figures are available for 3 financial years (2019/20–2021/22).
Control and charges
One person with significant control is registered. 1 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 14 Jan 2027.